Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites

• Status: Unknown status
• Trial end date: 2013-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the trial is to asses the efficacy and safety of sublingual annual immunotherapy in children with bronchial asthma and/or allergic rhinitis allergic to house dust mites.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Medical University of Lodz; Medical Universtity of Lodz

Criteria

Inclusion Criteria:

• patients with bronchial asthma and/or allergic rhinitis allergic to house dust mites first diagnosed at least 2 years before the study

Exclusion Criteria:

• active respiratory tract infection requiring antibiotic treatment within 4 weeks before the study

• hospitalisation due to asthma exacerbation during the 3 months before the first visit

• known contraindications of SIT according to the EAACI

• previous allergen immunotherapy

• use of systemic corticosteroids

• other clinically significant pulmonary, hematologic, hepatic, gastrointestinal, renal, endocrine, neurologic, cardiovascular, and/or mental diseases or malignancy that either put the patient at risk when participating in the study or could influence the results of the study